The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
In a report released today, Mark Massaro from BTIG reiterated a Buy rating on Guardant Health (GH – Research Report), with a price target of ...
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...
When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results